17.06.2013 Views

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Sunday, 17 March - <strong>EAU</strong> <strong>Programme</strong><br />

Abstract Session<br />

12.15 - 13.45 Making the diagnosis of bladder cancer<br />

Brown Hall 3 - Level S2<br />

Poster Session 31<br />

Chairs: J. Irani, Poitiers (FR)<br />

T.S. O’Brien, London (GB)<br />

Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes<br />

in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed<br />

by 2 minutes for discussion.<br />

* 362 Incidental diagnosis of bladder cancer in an obervational study: Clinical stage migration<br />

J.M. Gaya Sopena, J. Palou, B. Miñana, J.M. Cózar, R. Medina, I. De Zaragoza, F. De La Rosa, I. Ip De Coruña,<br />

I. Ip De Vall D’Hebron, M.J. Ribal (Barcelona, Murcia, Granada, Sevilla, Zaragoza, Madrid, La Coruña, Spain)<br />

363 The role of antiplatelet and anticoagulant therapy in the diagnosis of bladder cancer<br />

M. Moschini, A. Bettiga, G. Burgio, C. Maccagnano, L. Rocchini, F. Pellucchi, G. La Croce, R. Colombo (Milan,<br />

Italy)<br />

364 Expedient combination of urine markers enhances their diagnostic performance in the detection of<br />

urothelial carcinoma<br />

T. Todenhöfer, J. Hennenlotter, U. Kühs, S. Mohrhardt, M. Esser, S. Aufderklamm, J. Mundhenk, G. Gakis,<br />

A. Stenzl, C. Schwentner (Tübingen, Germany)<br />

365 Point-of-care testing for bladder cancer – the UBC rapid test on the concile ® Ω100 reader platform<br />

provides quantitative results<br />

T. Todenhöfer, J. Hennenlotter, R. Ritter, U. Hoffmann, P. Blutbacher, A. Deja, A. Hohneder, A. Stenzl,<br />

C. Schwentner (Tübingen, Germany)<br />

366 Bladder cancer detection by autofluorescence (ultraviolet) at 308nm (preliminary results)<br />

C. Egrot, M. Sibony, S.M. Al-Qahtani, O. Cussenot (Paris, France)<br />

367 Removing routine urine cytology assessment in the one stop haematuria clinic<br />

J.S. Phull, A.C. Carter, J.D. Osborne, T. Lloyd, S. Sloan, V. Shah (Newport, United Kingdom)<br />

368 Hematuria one stop clinic: First experience in Italy with 303 cases<br />

L. Carmignani, S. Casellato, S. Picozzi, G. Bozzini, C. Marenghi, V. Nicosia, M. Cosentino (San Donato<br />

Milanese, Italy)<br />

369 Acute imaging for hematuria in the United States: Costs and predictors from the Nationwide Emergency<br />

Department Sample<br />

K.R. Ghani, S. Sukumar, J.D. Sammon, W. Jeong, A. Sood, J.O. Peabody, M. Menon, Q-D. Trinh (Detroit,<br />

United States of America)<br />

370 Visible haematuria in patients under 40 years of age: Where do we stand<br />

O. Aboumarzouk, S. Mishriki, B. Somani, R. Vint, T. Lam (Aberdeen, United Kingdom)<br />

371 Preventive medical care in bladder cancer is possible: Risk-adapted screening in urology performed by<br />

IQUO-Germany<br />

G.C. Lüdecke, G. Geiges, F. König (Giessen, Berlin, Germany)<br />

<strong>EAU</strong> Milan <strong>2013</strong><br />

177<br />

Sunday

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!